nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—EGF—adrenal medulla—adrenal gland cancer	0.158	0.465	CbGeAlD
Sucralfate—FGG—adrenal cortex—adrenal gland cancer	0.0316	0.093	CbGeAlD
Sucralfate—FGG—adrenal gland—adrenal gland cancer	0.0228	0.0672	CbGeAlD
Sucralfate—FGB—gonad—adrenal gland cancer	0.0202	0.0595	CbGeAlD
Sucralfate—FGA—gonad—adrenal gland cancer	0.0173	0.0509	CbGeAlD
Sucralfate—FGA—pituitary gland—adrenal gland cancer	0.0169	0.0497	CbGeAlD
Sucralfate—EGF—gonad—adrenal gland cancer	0.0126	0.0372	CbGeAlD
Sucralfate—EGF—cardiac atrium—adrenal gland cancer	0.0126	0.0371	CbGeAlD
Sucralfate—EGF—pituitary gland—adrenal gland cancer	0.0123	0.0363	CbGeAlD
Sucralfate—EGF—adrenal gland—adrenal gland cancer	0.011	0.0324	CbGeAlD
Sucralfate—FGF2—pituitary gland—adrenal gland cancer	0.0109	0.032	CbGeAlD
Sucralfate—FGF2—adrenal gland—adrenal gland cancer	0.0097	0.0286	CbGeAlD
Sucralfate—ALB—adrenal gland—adrenal gland cancer	0.0038	0.0112	CbGeAlD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—BAD—adrenal gland cancer	0.000638	0.000966	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—BAD—adrenal gland cancer	0.000638	0.000966	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—BAD—adrenal gland cancer	0.000638	0.000966	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—GNRH1—adrenal gland cancer	0.000637	0.000965	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—PRKACA—adrenal gland cancer	0.000636	0.000962	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—BAD—adrenal gland cancer	0.000633	0.000957	CbGpPWpGaD
Sucralfate—EGF—Signaling by SCF-KIT—EGFR—adrenal gland cancer	0.000631	0.000954	CbGpPWpGaD
Sucralfate—EGF—Focal Adhesion—CTNNB1—adrenal gland cancer	0.000627	0.000949	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—BAD—adrenal gland cancer	0.000627	0.000949	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—BRAF—adrenal gland cancer	0.000625	0.000947	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—GNRH1—adrenal gland cancer	0.000624	0.000945	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—GNRH1—adrenal gland cancer	0.000624	0.000945	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000624	0.000945	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—BAD—adrenal gland cancer	0.000624	0.000945	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—BRAF—adrenal gland cancer	0.000624	0.000944	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—CDC42—adrenal gland cancer	0.000624	0.000944	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—IGF2—adrenal gland cancer	0.000607	0.000918	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000605	0.000915	CbGpPWpGaD
Sucralfate—EGF—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.000603	0.000913	CbGpPWpGaD
Sucralfate—EGF—Downstream signaling of activated FGFR—EGFR—adrenal gland cancer	0.000603	0.000913	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—IGF2—adrenal gland cancer	0.000601	0.00091	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000601	0.000909	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—GNAS—adrenal gland cancer	0.000596	0.000902	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB4—EGFR—adrenal gland cancer	0.000594	0.000899	CbGpPWpGaD
Sucralfate—FGF2—Constitutive PI3K/AKT Signaling in Cancer—EGFR—adrenal gland cancer	0.000593	0.000897	CbGpPWpGaD
Sucralfate—FGF2—Immune System—SH3KBP1—adrenal gland cancer	0.000592	0.000896	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—BAD—adrenal gland cancer	0.000591	0.000894	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—SPRY2—adrenal gland cancer	0.000583	0.000882	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—BRAF—adrenal gland cancer	0.000581	0.000879	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—adrenal gland cancer	0.000578	0.000875	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—SPRY2—adrenal gland cancer	0.000571	0.000864	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—SPRY2—adrenal gland cancer	0.000571	0.000864	CbGpPWpGaD
Sucralfate—FGA—Disease—PRKACA—adrenal gland cancer	0.00057	0.000863	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000569	0.000861	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TSHR—adrenal gland cancer	0.000568	0.00086	CbGpPWpGaD
Sucralfate—EGF—Downstream signal transduction—EGFR—adrenal gland cancer	0.000567	0.000858	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—BAD—adrenal gland cancer	0.000565	0.000856	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR—EGFR—adrenal gland cancer	0.000564	0.000854	CbGpPWpGaD
Sucralfate—EGF—EGF/EGFR Signaling Pathway—EGFR—adrenal gland cancer	0.000564	0.000854	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB2—EGFR—adrenal gland cancer	0.000561	0.00085	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—CDC42—adrenal gland cancer	0.000561	0.00085	CbGpPWpGaD
Sucralfate—EGF—DAP12 signaling—EGFR—adrenal gland cancer	0.000559	0.000846	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TSHR—adrenal gland cancer	0.000556	0.000842	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TSHR—adrenal gland cancer	0.000556	0.000842	CbGpPWpGaD
Sucralfate—EGF—Downstream signaling events of B Cell Receptor (BCR)—EGFR—adrenal gland cancer	0.000551	0.000834	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—EGFR—adrenal gland cancer	0.000548	0.00083	CbGpPWpGaD
Sucralfate—FGF2—Disease—SH3KBP1—adrenal gland cancer	0.000546	0.000827	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CDC42—adrenal gland cancer	0.000539	0.000816	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MEN1—adrenal gland cancer	0.000534	0.000808	CbGpPWpGaD
Sucralfate—FGF2—PI-3K cascade—EGFR—adrenal gland cancer	0.000534	0.000808	CbGpPWpGaD
Sucralfate—EGF—Fc epsilon receptor (FCERI) signaling—EGFR—adrenal gland cancer	0.000526	0.000796	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—EGFR—adrenal gland cancer	0.000526	0.000796	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR in disease—EGFR—adrenal gland cancer	0.000526	0.000796	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MEN1—adrenal gland cancer	0.000523	0.000792	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MEN1—adrenal gland cancer	0.000523	0.000792	CbGpPWpGaD
Sucralfate—FGF2—PI3K/AKT activation—EGFR—adrenal gland cancer	0.000521	0.000789	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR—EGFR—adrenal gland cancer	0.000521	0.000789	CbGpPWpGaD
Sucralfate—FGF2—GAB1 signalosome—EGFR—adrenal gland cancer	0.000517	0.000783	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR in Cancer—EGFR—adrenal gland cancer	0.000516	0.000782	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	0.000515	0.000779	CbGpPWpGaD
Sucralfate—EGF—Signaling by PDGF—EGFR—adrenal gland cancer	0.000514	0.000778	CbGpPWpGaD
Sucralfate—FGF2—Disease—ZNRF3—adrenal gland cancer	0.000514	0.000778	CbGpPWpGaD
Sucralfate—EGF—Disease—SPRY2—adrenal gland cancer	0.000509	0.00077	CbGpPWpGaD
Sucralfate—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—adrenal gland cancer	0.000505	0.000765	CbGpPWpGaD
Sucralfate—EGF—Focal Adhesion—EGFR—adrenal gland cancer	0.000497	0.000752	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000495	0.000749	CbGpPWpGaD
Sucralfate—EGF—B Cell Activation—EGFR—adrenal gland cancer	0.000486	0.000736	CbGpPWpGaD
Sucralfate—FGA—Disease—CDC42—adrenal gland cancer	0.000484	0.000732	CbGpPWpGaD
Sucralfate—EGF—Disease—MEN1—adrenal gland cancer	0.000466	0.000706	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	0.000466	0.000705	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—TP53—adrenal gland cancer	0.00046	0.000697	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000442	0.000668	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—BAD—adrenal gland cancer	0.000435	0.000658	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—PRKACA—adrenal gland cancer	0.000419	0.000634	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000415	0.000629	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000412	0.000623	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PRKACA—adrenal gland cancer	0.000408	0.000617	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—CDC42—adrenal gland cancer	0.000402	0.000609	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—PRKACA—adrenal gland cancer	0.000402	0.000609	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PRKACA—adrenal gland cancer	0.000399	0.000605	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PRKACA—adrenal gland cancer	0.000399	0.000605	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—EGFR—adrenal gland cancer	0.000399	0.000604	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—BRAF—adrenal gland cancer	0.000396	0.000599	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000395	0.000598	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—BAD—adrenal gland cancer	0.000392	0.000593	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.00039	0.00059	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—GNRH1—adrenal gland cancer	0.00039	0.00059	CbGpPWpGaD
Sucralfate—FGA—Disease—TERT—adrenal gland cancer	0.000388	0.000587	CbGpPWpGaD
Sucralfate—EGF—Immune System—PRKACA—adrenal gland cancer	0.000386	0.000584	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000383	0.000579	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—EGFR—adrenal gland cancer	0.000382	0.000578	CbGpPWpGaD
Sucralfate—FGF2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.000382	0.000578	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—BAD—adrenal gland cancer	0.000376	0.00057	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—EGFR—adrenal gland cancer	0.000376	0.000569	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00036	0.000545	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—EGFR—adrenal gland cancer	0.000359	0.000543	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—EGFR—adrenal gland cancer	0.000358	0.000542	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—EGFR—adrenal gland cancer	0.000357	0.000541	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SPRY2—adrenal gland cancer	0.000356	0.000539	CbGpPWpGaD
Sucralfate—EGF—Disease—PRKACA—adrenal gland cancer	0.000356	0.000539	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—EGFR—adrenal gland cancer	0.000355	0.000538	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CDC42—adrenal gland cancer	0.000355	0.000538	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—EGFR—adrenal gland cancer	0.000354	0.000535	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—EGFR—adrenal gland cancer	0.000349	0.000528	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TSHR—adrenal gland cancer	0.000347	0.000526	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CDC42—adrenal gland cancer	0.000346	0.000523	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CDC42—adrenal gland cancer	0.000341	0.000517	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CDC42—adrenal gland cancer	0.000339	0.000513	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CDC42—adrenal gland cancer	0.000339	0.000513	CbGpPWpGaD
Sucralfate—FGA—Disease—BAD—adrenal gland cancer	0.000338	0.000511	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IGF2—adrenal gland cancer	0.000333	0.000505	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—EGFR—adrenal gland cancer	0.000333	0.000504	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—EGFR—adrenal gland cancer	0.000333	0.000504	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—EGFR—adrenal gland cancer	0.000333	0.000504	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—GNAS—adrenal gland cancer	0.00033	0.0005	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—EGFR—adrenal gland cancer	0.00033	0.000499	CbGpPWpGaD
Sucralfate—EGF—Immune System—CDC42—adrenal gland cancer	0.000327	0.000495	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—EGFR—adrenal gland cancer	0.000327	0.000495	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MEN1—adrenal gland cancer	0.000327	0.000494	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IGF2—adrenal gland cancer	0.000327	0.000494	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IGF2—adrenal gland cancer	0.000327	0.000494	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—EGFR—adrenal gland cancer	0.000325	0.000492	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—GNAS—adrenal gland cancer	0.000324	0.00049	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—GNAS—adrenal gland cancer	0.000324	0.00049	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IGF1R—adrenal gland cancer	0.000322	0.000488	CbGpPWpGaD
Sucralfate—FGF2—Disease—SPRY2—adrenal gland cancer	0.000322	0.000488	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IGF1R—adrenal gland cancer	0.000316	0.000478	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IGF1R—adrenal gland cancer	0.000316	0.000478	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000313	0.000474	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—TP53—adrenal gland cancer	0.000312	0.000472	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—EGFR—adrenal gland cancer	0.000308	0.000466	CbGpPWpGaD
Sucralfate—FGA—Disease—BRAF—adrenal gland cancer	0.000307	0.000465	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—TP53—adrenal gland cancer	0.000305	0.000462	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—TP53—adrenal gland cancer	0.000305	0.000462	CbGpPWpGaD
Sucralfate—EGF—Disease—CDC42—adrenal gland cancer	0.000302	0.000457	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.000299	0.000453	CbGpPWpGaD
Sucralfate—FGF2—Disease—MEN1—adrenal gland cancer	0.000295	0.000447	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	0.000295	0.000446	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.000279	0.000423	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TERT—adrenal gland cancer	0.000277	0.00042	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TERT—adrenal gland cancer	0.000272	0.000411	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TERT—adrenal gland cancer	0.000272	0.000411	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.000269	0.000407	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000263	0.000398	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—CTNNB1—adrenal gland cancer	0.000258	0.00039	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PRKACA—adrenal gland cancer	0.000249	0.000377	CbGpPWpGaD
Sucralfate—FGA—Disease—PTGS2—adrenal gland cancer	0.000248	0.000376	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—BAD—adrenal gland cancer	0.000248	0.000375	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000247	0.000373	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PRKACA—adrenal gland cancer	0.000244	0.000369	CbGpPWpGaD
Sucralfate—EGF—Disease—TERT—adrenal gland cancer	0.000242	0.000367	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—BAD—adrenal gland cancer	0.000241	0.000365	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—BAD—adrenal gland cancer	0.000238	0.00036	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—BAD—adrenal gland cancer	0.000236	0.000358	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—BAD—adrenal gland cancer	0.000236	0.000358	CbGpPWpGaD
Sucralfate—EGF—Immune System—BAD—adrenal gland cancer	0.000228	0.000345	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—EGFR—adrenal gland cancer	0.000227	0.000343	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000226	0.000341	CbGpPWpGaD
Sucralfate—FGF2—Disease—PRKACA—adrenal gland cancer	0.000225	0.000341	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TP53—adrenal gland cancer	0.000224	0.000339	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—POMC—adrenal gland cancer	0.000222	0.000337	CbGpPWpGaD
Sucralfate—FGA—Disease—CTNNB1—adrenal gland cancer	0.000222	0.000336	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TSHR—adrenal gland cancer	0.00022	0.000333	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—BRAF—adrenal gland cancer	0.00022	0.000333	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—POMC—adrenal gland cancer	0.000218	0.00033	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—POMC—adrenal gland cancer	0.000218	0.00033	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—BRAF—adrenal gland cancer	0.000215	0.000326	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—BRAF—adrenal gland cancer	0.000215	0.000326	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000212	0.000321	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CDC42—adrenal gland cancer	0.000211	0.00032	CbGpPWpGaD
Sucralfate—EGF—Disease—BAD—adrenal gland cancer	0.000211	0.000319	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CDC42—adrenal gland cancer	0.000207	0.000313	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MEN1—adrenal gland cancer	0.000207	0.000313	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—EGFR—adrenal gland cancer	0.000204	0.000309	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IGF2—adrenal gland cancer	0.000204	0.000308	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—GNAS—adrenal gland cancer	0.000202	0.000306	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—SPARC—adrenal gland cancer	0.000201	0.000304	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IGF1R—adrenal gland cancer	0.000197	0.000298	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SDHB—adrenal gland cancer	0.000196	0.000297	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—EGFR—adrenal gland cancer	0.000196	0.000297	CbGpPWpGaD
Sucralfate—EGF—Disease—BRAF—adrenal gland cancer	0.000192	0.00029	CbGpPWpGaD
Sucralfate—FGF2—Disease—CDC42—adrenal gland cancer	0.000191	0.000289	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TP53—adrenal gland cancer	0.00019	0.000288	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—CTNNB1—adrenal gland cancer	0.000185	0.00028	CbGpPWpGaD
Sucralfate—FGA—Disease—EGFR—adrenal gland cancer	0.000176	0.000266	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PRKACA—adrenal gland cancer	0.00017	0.000257	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TERT—adrenal gland cancer	0.00017	0.000257	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CTNNB1—adrenal gland cancer	0.000163	0.000247	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000159	0.00024	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000158	0.000239	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000156	0.000235	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000156	0.000235	CbGpPWpGaD
Sucralfate—EGF—Disease—PTGS2—adrenal gland cancer	0.000155	0.000235	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000154	0.000234	CbGpPWpGaD
Sucralfate—FGF2—Disease—TERT—adrenal gland cancer	0.000153	0.000232	CbGpPWpGaD
Sucralfate—EGF—Immune System—CTNNB1—adrenal gland cancer	0.00015	0.000227	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—BAD—adrenal gland cancer	0.000148	0.000223	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000147	0.000222	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—EGFR—adrenal gland cancer	0.000146	0.000222	CbGpPWpGaD
Sucralfate—FGF2—Immune System—BAD—adrenal gland cancer	0.000144	0.000219	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—CDC42—adrenal gland cancer	0.000144	0.000218	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IGF2—adrenal gland cancer	0.000139	0.00021	CbGpPWpGaD
Sucralfate—EGF—Disease—CTNNB1—adrenal gland cancer	0.000139	0.00021	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—GNAS—adrenal gland cancer	0.000138	0.000208	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—POMC—adrenal gland cancer	0.000136	0.000206	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—BRAF—adrenal gland cancer	0.000134	0.000203	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CDC42—adrenal gland cancer	0.000134	0.000203	CbGpPWpGaD
Sucralfate—FGF2—Disease—BAD—adrenal gland cancer	0.000133	0.000202	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—EGFR—adrenal gland cancer	0.000129	0.000196	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IGF2—adrenal gland cancer	0.000129	0.000195	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GNAS—adrenal gland cancer	0.000128	0.000194	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SDHD—adrenal gland cancer	0.000126	0.000191	CbGpPWpGaD
Sucralfate—ALB—Metabolism—RRM1—adrenal gland cancer	0.000126	0.000191	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—EGFR—adrenal gland cancer	0.000126	0.00019	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000125	0.000189	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—EGFR—adrenal gland cancer	0.000124	0.000188	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—EGFR—adrenal gland cancer	0.000123	0.000187	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—EGFR—adrenal gland cancer	0.000123	0.000187	CbGpPWpGaD
Sucralfate—FGF2—Disease—BRAF—adrenal gland cancer	0.000121	0.000184	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000119	0.00018	CbGpPWpGaD
Sucralfate—EGF—Immune System—EGFR—adrenal gland cancer	0.000119	0.00018	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000117	0.000177	CbGpPWpGaD
Sucralfate—EGF—Disease—EGFR—adrenal gland cancer	0.00011	0.000166	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TERT—adrenal gland cancer	0.000107	0.000162	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TP53—adrenal gland cancer	0.000106	0.00016	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TP53—adrenal gland cancer	0.000103	0.000157	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TP53—adrenal gland cancer	0.000103	0.000157	CbGpPWpGaD
Sucralfate—FGF2—Disease—PTGS2—adrenal gland cancer	9.81e-05	0.000148	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CTNNB1—adrenal gland cancer	9.71e-05	0.000147	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CTNNB1—adrenal gland cancer	9.5e-05	0.000144	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MED12—adrenal gland cancer	9.43e-05	0.000143	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—BAD—adrenal gland cancer	9.34e-05	0.000141	CbGpPWpGaD
Sucralfate—FGF2—Disease—CTNNB1—adrenal gland cancer	8.77e-05	0.000133	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—POMC—adrenal gland cancer	8.61e-05	0.00013	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—BRAF—adrenal gland cancer	8.5e-05	0.000129	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	8.43e-05	0.000128	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—EGFR—adrenal gland cancer	7.69e-05	0.000116	CbGpPWpGaD
Sucralfate—FGF2—Immune System—EGFR—adrenal gland cancer	7.53e-05	0.000114	CbGpPWpGaD
Sucralfate—FGF2—Disease—EGFR—adrenal gland cancer	6.95e-05	0.000105	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PRKACA—adrenal gland cancer	6.88e-05	0.000104	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6.72e-05	0.000102	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TP53—adrenal gland cancer	6.46e-05	9.78e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CTNNB1—adrenal gland cancer	6.14e-05	9.3e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GNAS—adrenal gland cancer	5.58e-05	8.44e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ABCB1—adrenal gland cancer	5.47e-05	8.28e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EGFR—adrenal gland cancer	4.87e-05	7.37e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TP53—adrenal gland cancer	4.4e-05	6.65e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TP53—adrenal gland cancer	4.09e-05	6.19e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—POMC—adrenal gland cancer	3.75e-05	5.68e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTGS2—adrenal gland cancer	2.99e-05	4.53e-05	CbGpPWpGaD
